Areas of Focus: Biotechnology & Pharmaceuticals
Shawn focuses on a range of sectors including biotechnology, specialty pharmaceuticals and new technology life sciences tools. Previously he served as the Head of Investment and Merchant Banking at Noble Life Science Partners, a division of Noble Capital Markets. Prior to Noble, he was a Founding Partner at Variant Research Corporation and Senior Vice President of Avalon Research Group both of which focused on long and short life sciences equity research.
Shawn is highly proficient in scientific and corporate due diligence with the ability to leverage proprietary relationships with scientific KOLs and C-level life sciences executives. He has a demonstrated ability of creating and identifying emerging life sciences companies with successful management teams, milestone outcomes and investment returns. Shawn is a Co-Founder and former Chairman of ZyVersa Therapeutics (formerly Variant Pharmaceuticals) and former board member of Pelican Therapeutics (acquired by Heat Biologics in 2017).
Shawn is a graduate of the University of Denver and currently resides in South Florida with his wife and two children. Shawn also serves on Tribal Capital Market’s Equity Capital Life Sciences Division and holds FINRA series 7, 24, 63, 65 and 79 licenses.